Mealey's (July 18, 2018, 12:02 PM EDT) -- FORT PIERCE, Fla. — A federal judge in Florida on July 9 found that the methodology underlying a couple’s general causation expert’s study that revealed a link between use of the leukemia drug Tasigna and cardiovascular events was reliable but said the expert could not testify about the severity or rapid progression of the atherosclerosis associated with the drug’s use (Dennis McWilliams, et al. v. Novartis AG, et al., No. 17-cv-14302-ROSENBERG/MAYNARD, S.D. Fla., 2018 U.S. Dist. LEXIS 113858)....